Back

Clinical determinants of oral anticoagulant selection in atrial fibrillation: insights from an Argentine registry

28 August 2026 (16:15 - 16:45)
Organised by: Logo
Congress Presentation Part of: Balancing stroke prevention and bleeding risk in atrial fibrillation Oral Anticoagulation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marcelo Sergio Trivi

Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires (Argentina)

1 More presentation in this session

Presentation thumbnail
Association of antithrombotic therapy with cerebral microbleeds: a cross-sectional, multicentre analysis
Mr J. Gruthoelter (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Balancing stroke prevention and bleeding risk in atrial fibrillation

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
14 April 2026
thumbnail
Congress Presentation
Non-vitamin K antagonist oral anticoagulants versus warfarin and the risk of cataract in patients with atrial fibrillation: A real-world cohort study
29 August 2026
thumbnail
Congress Presentation
Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project
1 September 2024
thumbnail
Congress Presentation
Factors associated with delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources